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The advent of protein display systems has provided access
to tailor-made protein binders by directed evolution. We
introduce a new in vitro display system, bead surface
display (BeSD), in which a gene is mounted on a bead via
strong non-covalent (streptavidin/biotin) interactions and
the corresponding protein is displayed via a covalent
thioether bond on the DNA. In contrast to previous mono-
valent or low-copy bead display systems, multiple copies of
the DNA and the protein or peptide of interest are dis-
played in defined quantities (up to 106 of each), so that flow
cytometry can be used to obtain a measure of binding
affinity. The utility of the BeSD in directed evolution is
validated by library selections of randomized peptide
sequences for binding to the anti-hemagglutinin (HA) anti-
body that proceed with enrichments in excess of 103 and
lead to the isolation of high-affinity HA-tags within one
round of flow cytometric screening. On-bead Kd measure-
ments suggest that the selected tags have affinities in the
low nanomolar range. In contrast to other display systems
(such as ribosome, mRNA and phage display) that are
limited to affinity panning selections, BeSD possesses the
ability to screen and rank binders by their affinity in vitro,
a feature that hitherto has been exclusive to in vivo multi-
valent cell display systems (such as yeast display).
Keywords: antibody/directed evolution/emulsion PCR/phage
display/protein display
Introduction
High-affinity protein binders with unique specificity have
become indispensable reagents in basic research, large-scale
proteomic studies and also in therapy, where they represent the
fastest-growing segment of the pharmaceutical market. While
in nature such binders are generated by the immune system
from antibody repertoires, modern display technologies (see
Fig. 1 for an overview of existing display constructs)
(Leemhuis et al., 2005; Douthwaite and Jackson, 2012) have
expanded the range of protein scaffolds used as binders
(Gebauer and Skerra, 2009) and enabled better exploration of
sequence space. Selections can be performed under in vitro
conditions, avoiding animal experiments and bias arising from
constraints of the host environment (Michnick and Sidhu,
2008; Bradbury et al., 2011). However, protein binders are still
not available for all desirable targets and in many instances
exhibit imperfect selectivity, lack thermal stability or their
suboptimal pharmacokinetic properties necessitate further im-
provement for clinical applications. The properties of the
selected binders are in no small part a function of the selection
system used to isolate them, hence, a variety of powerful
approaches has been developed.
In the most established technology, phage display, the
protein of interest (POI) is fused to a coat protein, e.g. via the
N-terminus of the minor (pIII) or major (pVIII) capsid pro-
teins (Fig. 1, A5) (Willats, 2002; Sidhu, 2005; Paschke, 2006).
In generating the display construct, the fusion protein is trans-
located across the Escherichia coli cytoplasmic membrane to
the periplasm, where it is integrated into the coat of the bac-
teriophage. Analogous display constructs can be built with
bacteria (Francisco et al., 1993; Georgiou et al., 1997; van
Bloois et al., 2010) and yeast (Boder and Wittrup, 1997; Gai
and Wittrup, 2007) (Fig. 1, A7 and A8). In all of these
systems, the POI is covalently linked to proteins on the surface
of the organism, and thus indirectly to the genotype as well (as
long as the cells do not undergo lysis). Expression occurs
in vivo, but subsequent selections are carried out in vitro.
A number of alternative systems take the expression step
into an in vitro setting. Ribosome display (Fig. 1, A3) is a non-
covalent display system in which the nascent polypeptide
chain is coupled to its coding mRNA via the ribosome by de-
leting a stop codon and avoiding dissociation at high Mg2þ
concentration and low temperatures (Hanes and Pluckthun,
1997; Dreier and Pluckthun, 2012). Similarly, mRNA display
(Fig. 1, A4) relies on connecting genotype and phenotype in
the ribosome, although here the bond is covalent via the ribo-
somal inhibitor puromycin (Roberts and Szostak, 1997; Cho
et al., 2000). The benefits of a cell-free format have been
demonstrated by comparisons of affinity and diversity of
binders generated by ribosome and phage display (Groves
et al., 2006; Thom et al., 2006). These quantitative compari-
sons suggest that the avoidance of the bottlenecks of trans-
formation efficiency and compatibility with cellular
machinery improve the success of selections and favor in vitro
methods. Two conceptually similar in vitro systems, MHaeIII-
(Bertschinger and Neri, 2004; Bertschinger et al., 2007) and
SNAP display (Stein et al., 2007; Kaltenbach et al., 2011;
Kaltenbach and Hollfelder, 2012; Houlihan et al., 2013)
(Fig. 1, A1 and A2) rely on a link between the protein and
DNA (instead of the less stable RNA) that is covalent (in con-
trast to the delicate mRNA–ribosome–polypeptide ternary
complex in ribosome display). This linkage is brought about
by compartmentalizing a single DNA molecule in each
water-in-oil emulsion microdroplet, expressing the POI in
vitro and retaining both together by the microdroplet
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boundary. Up to 109 droplets per microliter of aqueous solu-
tion can be made by vortexing or using microfluidic devices
(Keppler et al., 2003; Courtois et al., 2008; Huebner et al.,
2008; Schaerli et al., 2009; Theberge et al., 2010; Devenish
et al., 2012; Kaltenbach and Hollfelder, 2012; Kaltenbach
et al., 2012). Adjustment of the Poisson distribution ensures
that in the majority of occupied droplets only one copy of
DNA exists, rendering them ‘monoclonal’. The corresponding
protein is expressed as a fusion with a protein tag that reacts
covalently with a label on its coding DNA (a modified base
(Bertschinger and Neri, 2004; Bertschinger et al., 2007) or a
benzylguanine (BG) (Keppler et al., 2003) coupled to DNA).
In addition to the nature of the genotype–phenotype
linkage, display systems are distinguished by the way selections
are performed (Fig. 1, B1 and B2). Selections on phage-
displayed proteins (with typically one or few copies of each
variant displayed per phage (Barbas et al., 2004; Clackson and
Lowman, 2004) and in current in vitro systems are carried out
by ‘affinity panning’ based on off-rates (koff ) and therefore
highly dependent on the conditions employed (e.g. the duration
and number of washes in the panning procedure). Variants are
recovered if their affinity is above a pre-set, but not necessarily
precisely defined, threshold. When the display constructs
contain a larger number of proteins—e.g. 104 copies dis-
played on bacteria (Chen et al., 1996; Andreoni et al., 1997;
Christmann et al., 2001; Löfblom et al., 2005, 2007; Rockberg
et al., 2008) or 30 000 copies on yeast (Boder and Wittrup,
1997)—selections can be based on the measurement of the
binding property of every clone. Here, flow cytometry is
employed to rank and sort binders. Variation of the concentra-
tion of a fluorescent ligand incubated with the display construct
and measurement of the extent to which it, sticks determines
selection pressure akin to Kd titrations. This ranking gives
access to populations of weaker and stronger binders depending
on the chosen fluorescence threshold in flow cytometry. While
‘panning’ has to be followed up by further labor-intensive bio-
physical analysis, flow cytometry immediately identifies the
best binders in a given sample at high throughput and offers the
opportunity to select binders by affinity ranking (based on their
Kd).
In vitro alternatives to cell-based multivalent display systems
would be desirable for selections under conditions that are not
compatible with a cellular host, for display of proteins that are
toxic and with relative freedom in the size (5PRIME, 2009), and
type (Davies et al., 2005) of expressed proteins. The display of
nucleic acids and proteins on a bead is the in vitro equivalent of
such multivalent cell display systems. Initially, single DNA
copies were immobilized on beads and droplet compartmental-
ization used to capture multiple proteins expressed from these
templates (Sepp et al., 2002; Griffiths and Tawfik, 2003). Later
studies achieved DNA amplification (Gan et al., 2008, 2010;
Paul et al., 2013). However, the inefficiency of amplification of
bead-bound DNA templates in droplets has in most cases
limited this approach to small constructs of ,1000 bp (Gan
et al., 2008, 2010). The amplification of larger constructs
remained unquantified and must be presumed to be inefficient:
to the extent that even green fluorescence protein (GFP) could
not be detected by its own fluorescence, but required an
exhaustively-labeled anti-GFP antibody (Paul et al., 2013). In
all these studies, the number of displayed nucleic acids after
amplification and the number of displayed proteins also
remained undetermined, compromising the quantitative readout
on which selection is based. In single DNA bead display (Sepp
et al., 2002), hits were detected by tyramide signal amplifica-
tion, which allows the identification of hits, but not their fine
quantitative ranking that is possible, e.g. in yeast display
(VanAntwerp and Wittrup, 2000). Furthermore, the use of anti-
body interactions in building up the display construct limited its
stability and thus the robustness of the selection schemes.
In this work, we describe a new type of display construct
that presents up to 106 copies of both the DNA template and
the encoded protein, each of which can be precisely con-
trolled. Bead surface display (BeSD) combines the advantages
of multivalency seen in current cell-based approaches with the
Fig. 1. Overview of current display systems. (A) Cartoon representation of
different genotype–phenotype linkages used in directed evolution (genotype:
red; phenotype: blue; entity providing the genotype–phenotype link (protein,
ribosome, phage, cell or bead): light brown; the images are not drawn to
scale). The specific systems shown are DNA-display: M-HaeIII display (A1),
SNAP display (A2); RNA display: ribosome display (A3), mRNA display
(A4); phage display (A5). The systems shown in A1–A5 have one copy of the
genotype and one or a few copies of the expressed protein. By contrast,
cell-display methods (bacterial: A7; yeast: A8) have multiple copies of
genotype and phenotype. This work describes BeSD (A6), which shares
features of both formats, as the displayed protein is expressed in vitro, but
displayed in up to 106 copies (rather than a single one in other in vitro
systems), thus endowing BeSD with features that were hitherto exclusive to
cell-display systems. (B) The display formats imply different selection
approaches: panning (shown in B1 for phage display (A5), but carried out
analogously for systems A1–4) is based on immobilization of the target on a
surface and capture of protein binders by affinity selection. In this process
quantitative analysis and direct control of ligand-binding parameters are
impossible. Further labor-intensive biophysical measurements are often
necessary to assess the strength and specificity of affinity-selected binders. By
contrast, flow cytometry (FACS) measures the number of fluorescent target
molecules bound directly (B2) and thus screens every mutant in the library,
allowing a quantitative threshold to be set as the basis for a considered choice
during selection. POI, protein or peptide of interest.
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potential of in vitro methods, while avoiding their respective
shortcomings arising from low transformation efficiency
(e.g. in yeast display), and lack of display construct stability
(e.g. in RNA or ribosome display). The method has been vali-
dated by screening libraries of the hemagglutinin (HA)-tag
with three randomized positions and successfully isolating the
wild-type (WT) HA-tag sequence after a single round of
screening. The observation of binding saturation curves
(reflecting Kd values of the isolated variants) of candidates dis-
played on beads supports the idea that selection is based on
direct assessment of the amount of bound ligand. The course
of selection during such more informed ‘deep mining’ is thus
based on a genuine biophysical measurement, and validation
of the hits is possible in the same format. The straightforward
protocol and reliable procedures provide a new practical route
to expanding the scope of molecular evolution by functional
ranking of in vitro expressed libraries.
Materials and methods
Standard procedures
Expression constructs. The plasmid pIVEX-SNAP-HA was
derived from pIVEX-SNAP-GFP (Keppler et al., 2003;
Mollwitz et al., 2012) by double digestion with NotI and
BamHI and subsequent ligation with T4 DNA ligase (1 h,
room temperature) to the overlapping oligonucleotides F-HA
and R-HA coding for the HA-tag (Supplementary Table S3).
F-HA and R-HA were mixed and incubated with a ramp from
858C to room temperature to let them anneal, before ligation
into the digested vector. pIVEX-SNAP-GFP contains the R30I
mutant of the SNAP-tag (Sun et al., 2011). The plasmid
pIVEX-anchor was derived from pIVEX-SNAP-GFP by
double digestion with BglII and BamHI, so that the region
consisting of promoter, ribosomal binding site and SNAP-
GFP were excised. A restriction digest was followed by blunt-
ing of 30- and 50-overhangs using T4 DNA polymerase (NEB)
and by self-ligation with T4 DNA ligase (1 h at room tempera-
ture). The ligated plasmids were transformed into chemically
competent TOP10 cells according to the manufacturers’
instructions. Plasmids pIVEX-SNAP-GFP and pIVEX-anchor
are available via the Addgene repository.
HA library construction. HA-NNS libraries (incorporating a
degenerate codon in which N stands for an equimolar mixture
of all four nucleotides and S for an equimolar mixture of G and
C) were created by whole plasmid amplification starting from
pIVEX-SNAP-HA as a template using Herculase II Fusion
DNA Polymerase (Agilent). The following primer pairs
(Supplementary Table S4) were used: F-HA-NNS1 and R-HA-
NNS1 for the HA-D7 library, F-HA-NNS2 and R-HA-NNS2
for the HA-Y8A9 library and F-HA-NNS2 and R-HA-NNS3
for the HA-D7Y8A9 library.
Preparation of spiking anchors. These were created by stand-
ard polymerase chain reaction (PCR) using the vector pIVEX-
anchor as a template with the primers F-BB and R2-BG. After
PCR purification (QIAquick PCR Purification Kit, Qiagen) the
desired number of spiking anchors was incubated with beads.
DNA quantification on beads via real-time PCR. Beads were
diluted and counted with a hemocytometer (Marienfeld,
Superior). Each sample contained 500–2000 beads, 0.8 mM
of each primer (F-RT-1 and R-RT-1) and 2X SensiMix SYBR
No-ROX Kit (Bioline). The RT-PCR (Corbett Research
Rotor-Gene 6000) program started with an initial step of
10 min at 958C followed by 40 cycles of 958C for 10 s, 608C
for 10 s and 728C for 5 s. Reactions were performed at least in
duplicate and a standard curve was constructed using known
concentrations of template DNA in the range 104–109 DNA
copies per reaction. The number of DNA copies per reaction
was calculated (using the software accompanying the
Rotor-Gene 6000 series) and divided by the number of beads/
reaction and by the correction factor 0.3 (fraction of beads
bearing DNA out of the total amount of beads, see
Supplementary Table S1). The number of anchors immobi-
lized on the beads were quantified in the same way, except that
primers F-RT-1 and R2 were used. The quantification of tem-
plate and anchors from beads recovered after sorting showed
no significant differences from the data obtained before in
vitro expression.
Fluorescence imaging. The expression of the SNAP-GFP
fusion allowed imaging with a fluorescence microscope
(Olympus Bx51) at a 10 enlargement ratio. Fluorescence
images (Supplementary Fig. S3) were acquired with an inte-
gration interval of 5–10 s, depending on the concentration of
expressed protein.
Affinity assays on beads. The beads were coated with anchors
(Step 4, Fig. 1) and incubated for 1 h in phosphate-buffered
saline (PBS) containing skimmed milk (3%, w/v). Then,
SNAP-HA was expressed with PURExpressTM (according to
the manufacturer’s instructions), added to the beads and incu-
bated for 20 min at 378C. The unbound SNAP-HA was
removed by washing the beads (once with PBS containing
0.05% Tween20, then twice with PBS). The beads were incu-
bated with Alexa488-labeled anti-HA antibody (0.1–450 nM).
After 30 min of incubation at room temperature, the unbound
antibody was removed by washing (once with PBS containing
0.05% Tween20 and once with PBS only). The fluorescence of
the beads was analyzed by flow cytometry (Cytek DxP8) and
the data are displayed in Fig. 7. The normalized median fluores-
cence curves were fitted to the Hill equation (with the exponen-
tial set to 2) (Goutelle et al., 2008) using Origin Pro 8.
Protocol for an evolution cycle using BeSD
The following procedure was optimized for ease of handling,
robustness and reproducibility. The following steps refer to
Fig. 2.
Step 1a—Preparation of the PCR reaction. Bioline BioTaq
PCR mix (BioTaq buffer (10), 2 mM MgCl2, 0.25 mM of
each dNTP and 4.5 U DNA polymerase), 50-modified biotin-
forward primer (F-BB, 0.2 mM), 0.2 mM of BG-modified
reverse primer (R2-BG) (prepared as described in (Keppler
et al., 2003; Stein et al., 2007; Kaltenbach and Hollfelder,
2012; Kaltenbach et al., 2012; Paul et al., 2013)) or unmodi-
fied reverse primer R2 or R3, 1.7  107 copies of DNA tem-
plate (unless otherwise stated in the text) and 9  105
streptavidin-coated beads (SiO2-MAG-SA-S1964, 5.18 mm,
microparticles GmbH) were mixed to give a total volume of
18 ml. Amplification was also possible in the presence of each
primer (1 mM) with other polymerases in place of BioTaq, e.g.
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2.5 Titanium Taq DNA polymerase (in 1 Titanium Taq
PCR buffer; ClonTech), Pfu Turbo DNA Polymerase (0.125 U
in 1 Cloned Pfu DNA polymerase reaction buffer, Agilent).
Step 1b—Emulsification. The aqueous phase was mixed with
three volumes of an oil phase. The oil phase was composed
of the fluorinated surfactant CS99B (a gift from Clive
Smith of Sphere Fluidics Ltd and Prof. C. Abell, University of
Cambridge) or EA surfactant (a gift from RainDance
Technologies) as a 4% (w/w) solution in HFE7500 oil
(n-C3F7CF(OC2H5)CF(CF3)2, 3M
TM NOVECTM) or alterna-
tively in DC749 fluid (30%, w/w; Dow Corning), Triton-100
(1%, w/w) and DC5225C formulation aid (39%, w/w; Dow
Corning) in silicone oil (AR 20, Sigma-Aldrich). The emul-
sion was created by vortexing aqueous and oil phase (in a ratio
of 1 : 3) in PCR tubes for 5 min. The emulsions made with the
HFE7500 were then pipetted through a 20 mm filter membrane
(Celltrics-Partec).
Step 2—Temperature cycling. The emulsion PCR (ePCR)
temperature program started with a ramp from 25 to 948C
(18C/s21), followed by 2 min at 948C and 30 cycles of de-
naturation (948C, 30 s), annealing (488C, 30 s) and extension
(728C, 1 min/kb). After a final extension step (728C, 5 min),
the samples were incubated first at 458C (5 min) and then at
258C (20 min) to allow the biotinylated PCR products in solu-
tion to attach to the beads.
Step 3—De-emulsification. Different de-emulsification proce-
dures were worked out for each oil phase. HFE7500 emulsions
were broken by adding water (100 ml, to increase the volume
of the aqueous phase for easier handling) and vortexing the
samples with 1H,1H,2H,2H-perfluorooctanol (PFO; 200 ml,
97%, Alfa Aesar). The upper phase was transferred in a clean
Eppendorf tube. Silicon oil emulsions were broken by adding
water-saturated butanol (800 ml). The aqueous and oil phases
were separated by spinning for 10 s in a microcentrifuge
(Eppendorf). The lower (aqueous) phase was collected.
Several repeats of this procedure were sometimes necessary
for complete de-emulsification. The beads were washed twice
(using a magnet to retain the beads) with deionized water or
PBS buffer (pH 7.4, containing 0.05% Tween) and resus-
pended in deionized water.
Step 4—Addition of the spiking anchors. A specific concen-
tration of the anchor DNA (usually 107 anchor molecules/
bead) was incubated with the beads, 5 mM Tris/HCl (pH 7.5),
0.5 mM ethylenediaminetetraacetic acid and 1 M NaCl at
room temperature for 30 min with shaking (Eppendorf
Thermomixer comfort). The non-immobilized spiking anchors
were removed by washing the beads twice with water. The
number of copies of PCR products and anchors per bead was
quantified by real-time PCR (RT-PCR) using primers F-RT-1
and R-RT-1 or F-RT-1 and R2, respectively.
Step 5 and 6—in vitro expression. In vitro transcription and
translation (IVTT) reactions were carried out using the
PURExpressTM in vitro Protein Synthesis Kit (NEB).
Reactions of 12.5 ml, consisted of 5 ml of solution A, 3.75 ml
of solution B and plasmid or ePCR-amplified DNA on beads
Fig. 2. Steps of a directed evolution cycle using BeSD. (1) A DNA library (coding for SNAP-tag-fused POI variants), streptavidin-coated beads and the PCR mix
containing BB forward primers and BG-labeled reverse primers are compartmentalized in water-in-oil emulsion droplets so that each compartment contains no
more than one DNA template and one bead. (2) DNA is amplified by ePCR and captured on the beads via a biotin–streptavidin linkage. (3) The emulsion is
broken, beads washed (to remove PCR mix components and unbound DNA that would compromise IVTT efficiency) and (4) spiking anchors added to provide
extra display functionalities. (5) A new emulsion is then created in the presence of an IVTT system. (6) Individual SNAP-tagged POI variants are expressed in vitro
and covalently linked to the BG-modified template DNA and spiking anchors via the SNAP-tag. (7) After de-emulsification and washing the beads are recovered.
(9) The beads are incubated with the labeled target. (9) The affinity for the target is measured by FACS and the selected beads are isolated. (10) The identity of the
selected clones is decoded after single-bead PCR by sequencing. Alternatively, the selected beads are used directly for another evolution cycle. The binding
affinity of each recovered variant can be measured by subsequent FACS analysis on the bead display construct (see Fig. 6b). POI, protein or peptide of interest.
L.Diamante et al.
716
in water. For emulsification, the aqueous phase was mixed
with three volumes of oil phase (as in Step 1b). The samples
were incubated at 378C for 4–6 h.
Step 7—De-emulsification. As in Step 4. The beads were
re-suspended in 50 ml of water.
Step 8—Addition of the fluorescently labeled target. The
beads were incubated with Alexa Fluorw 488-conjugate
anti-HA antibody (1 ml; monoclonal mouse IgG1, clone
16B12, Invitrogen) at room temperature for 30 min with
shaking. The beads were then washed three times with water
or PBS pH 7.5 (300 ml) to remove the unbound antibody
before analysis by flow cytometry.
Step 9—Fluorescence-activated sorting. Typically, at least
5000 beads were analyzed using a FACScan (Cytek DxP8).
Fluorescence-activated sorting was performed with a
BeckmanCoulter MoFlo MLS high-speed cell sorter. Beads
with fluorescence above a chosen fluorescence value (typically
1% of the population or less) were either individually sorted in
96-well PCR plates (1 bead/well) or pooled in Eppendorf
tubes for further use.
Step 10—Recovery PCR. Beads sorted by fluorescence-
activated cell sorting (FACS) and collected into 96-well plates
(one bead/well) were used directly, while pooled samples
were diluted to 1 bead/PCR tube and the genotype amplified
by PCR using BioTaq or Pfu Turbo DNA Polymerase
(Agilent) and primers F-T7 and R-T7 in a standard PCR proto-
col (performed as in Step 1, but without emulsification) and
the amplified products were sequenced.
Results and discussion
Assembly of a BeSD construct in microdroplets
Transient compartmentalization of genotype, phenotype and
microbeads in an emulsion microdroplet was used to establish
multivalent display of in vitro expressed proteins (Fig. 1, A6).
While compartmentalized in the droplet, single copies of the
DNA template are PCR amplified and affinity-captured on the
bead. These DNA-displaying beads are de-emulsified and
washed, then compartmentalized again to express the POI that
is also captured on the bead via the SNAP-tag (Keppler et al.,
2003; Stein et al., 2007; Kaltenbach and Hollfelder, 2012;
Kaltenbach et al., 2012; Paul et al., 2013). After removal of
the droplet boundary, multiple copies of a gene and the corre-
sponding protein are connected on the same bead, together
forming a monoclonal and multivalent display construct.
Selection cycles and the bioconjugation mechanisms involved
are explained in detail in the following paragraphs.
Display of a protein library on beads for a selection cycle
Figure 2 shows a typical round of BeSD in which a POI library
fused to the SNAP-tag is displayed on the beads. First, individ-
ual genes are encapsulated in water-in-oil droplets (Step 1)
and amplified by ePCR using bis-biotinylated (BB) and
BG-modified primers. The amplified DNA is immobilized on
the bead via the biotin–streptavidin interaction (Step 2). The
emulsion is broken, the PCR reagents removed by washing
(Step 3) and, if desired, the beads can be decorated with
additional BG-displaying moieties (spiking anchors) in readi-
ness for binding to the POI (Step 4). Protein expression is
carried out in newly formed droplet compartments (Step 6) to
ensure accurate genotype–phenotype linkage. Following ex-
pression, the POIs catalytically link to the beads via covalent
coupling of the SNAP-tag to the BG labels (Fig. 3). Finally,
FACS can be used to characterize the binding properties of
each variant against the desired fluorescent target (Steps 8 and
9). The genotype of each individual bead can be recovered and
further analyzed (Step 10). The multivalent genotype leads to
better recovery efficiency than do mono- or oligovalent
display systems (Supplementary Fig. S1). Furthermore,
display of up to 106 proteins per construct enables direct flow
cytometric screening, so that a quantitative affinity readout is
obtained and the selections are based on a threshold set at will.
Beads as the centerpiece for multivalent decoration
Commercial streptavidin-coated beads (diameter 5 mm) were
employed to provide a support for immobilizing DNA as well
as proteins (Fig. 3). The bridging function of the DNA is gen-
erated with two types of primers: BB forward primers (to bind
to the beads) and BG-modified reverse primers (to form a co-
valent bond with the expressed protein). The biotin–streptavi-
din bond is one of the strongest known in biology, with a
dissociation constant (Kd) in the order of 4  10214 M (Green,
1990). However, the Kd for immobilized streptavidin is
reduced compared with streptavidin in solution (Chivers et al.,
2010), so BB primers were adopted in an effort to partially
compensate for this loss of affinity (Dressman et al., 2003). In
order to capture the POI that was in vitro expressed from the
DNA template, the POI was fused with the SNAP-tag (AGT,
O6-alkylguanine-DNA-alkyltransferase) (Keppler et al., 2003;
Mollwitz et al., 2012) that reacts with the BG forming a cova-
lent thioether bond (Fig. 3).
Tight control of monoclonal compartmentalization
In vitro compartmentalization of single genes in water-in-oil
emulsion droplets was used as the linchpin for making the bead
display construct monoclonal. Emulsion droplets can be easily
generated by vortexing a mixture of oil, surfactant and water.
For formation of the display construct, a single DNA copy has
to be co-compartmentalized with a single bead. The concentra-
tion of single components can be adjusted according to the
Poisson distribution so that the number of droplets generated
exceeds the number of DNA molecules and beads used
(Nakano et al., 2003). Supplementary Table S1 shows the
probabilities for this desired situation. The correlation between
predicted and experimental values was tested by expressing
SNAP-GFP in emulsion. A range of template DNA quantities
were used for the ePCR step, resulting in different percentages
of beads being decorated with the template. Following IVTT in
emulsion, the accumulation of fluorescence in droplets can be
measured and used as an indicator of GFP expression. Image
processing allowed monitoring of the distribution of beads as
well as DNA-decorated beads (observed indirectly by the ex-
pression of GFP) (Supplementary Table S2 and Fig. S2).
Deviations from the theoretical values of bead occupancy (due
to the non-homogeneous generation of droplets, bead precipita-
tion, stickiness and stochastic events) are minimized by the dis-
tribution of template DNA at the ePCR step. Indeed, protein
production can only be observed in droplets containing beads
and follows a decrease that is proportional to the amount of
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DNA template used (55 and 23% for 1.7  107 and 4.6  106
copies of template DNA, respectively). This experiment can be
used to adjust co-encapsulation and monoclonal display.
Compatibility of emulsions with ePCR and IVTT
The reliability of selections is dependent on the maintenance
of compartmentalization during both ePCR at high tempera-
tures and IVTT at 378C. The stability of the emulsions was
thus verified by analysis of images before and after thermal
cycling (Supplementary Fig. S3) and after a typical IVTT in-
cubation (4–6 h, Supplementary Fig. S2). No coalescence was
observed among .3500 droplets for CS99B/HFE7500 and for
EA surfactant/HFE7500. The expression of a SNAP-GFP
fusion was used to quantify the expression and the presence of
fluorescence in beads-containing droplets (Supplementary Fig.
S2, panels A–C) shows that the CS99B/HFE7500 emulsion is
compatible with protein expression. The DC surfactants/sili-
cone oil emulsion previously reported (Margulies et al., 2005;
Novak et al., 2011) also led to the display of the SNAP-HA
fusion on beads (see Supplementary Table S3 and Fig. S4).
Efficient in vitro expression has also been shown for EA sur-
factant/HFE7500 (Courtois et al., 2008; Mazutis et al., 2009).
The CS99B/HFE7500 emulsion was our preferred combin-
ation (Supplementary Table S3), but these data suggest that
any biocompatible oil formulation that is able to resist an
ePCR cycle can be employed. Compared with the previously
published procedures that used mineral oils (Gan et al., 2008,
2010; Paul et al., 2013), the use of fluorinated oil/surfactant
combination simplifies the handling by allowing rapid, clean
de-emulsification with PFO. These surfactants do not interfere
with the subsequent steps of the protocol and there is no
need for treatment with specific buffers (Dressman et al.,
2003; Diehl et al., 2006), the use of water-soluble alcohols
(Kumaresan et al., 2008) or mechanical procedures (Margulies
et al., 2005). The immiscibility of PFO with water allows for
the quantitative recovery of beads in the desired buffer after a
simple mixing step.
Controlled display of multiple DNA copies (genotype
amplification)
It has previously been shown that ePCR on beads is character-
ized by poor efficiency for amplicons longer than 600 bp
(Tiemann-Boege et al., 2009), precluding longer sequence
reads (e.g. in 454 sequencing) (Rothberg and Leamon, 2008).
By contrast, our ePCR protocol yields up to 106 copies of DNA
per bead (as quantified by RT-PCR, see the Experimental
Section). Templates as large as 2750 bp could be amplified
(Fig. 4, Table I), suggesting that we are able to access larger
protein constructs than previous methods. In particular, the add-
ition of an incubation step at room temperature after the PCR
leads to a 150-fold increase in the number of DNA copies per
bead (Chivers et al., 2010). This step is likely to increase the
capture of BB PCR products to the streptavidin-coated beads
(Holmberg et al., 2005; Nguyen et al., 2005). Furthermore, a
previous protocol employed a covalently bound primer, leading
to inefficient ePCR (Paul et al., 2013). In our procedure, there is
no need for a preliminary coupling of DNA or primers to the
beads and both linear and plasmid DNA can be used as
Fig. 3. The molecular processes responsible for assembly of the BeSD display construct. Left: DNA molecules are bound to streptavidin-coated beads via biotin.
Right: At its other extremity, the DNA molecule carries a BG-label that reacts with an active site cysteine residue of the SNAP-tag (AGT,




templates for the ePCR. The amplification efficiency was
highly dependent on the polymerase employed (summarized in
Table I), with Titanium Taq giving about 103-fold more product
than the proofreading enzyme Pfu Turbo.
Spiking anchors modulate protein display frequency
(phenotype amplification)
In principle, the efficiency of PCR amplification would create
a limit to protein display frequency: each SNAP-tag can react
with one molecule of BG only, i.e. the number of displayed
molecules cannot exceed the number of successfully amplified
genotypes. Limits in the display frequency will reduce the sen-
sitivity of subsequent binding assays. For example, at least 103
copies of the template DNA per bead are required for detection
of the expressed SNAP-GFP fusion in flow cytometry
(Supplementary Fig. S5A). To provide further valencies for
POI capture, free streptavidin moieties on the bead were deco-
rated with ‘spiking anchors’ (non-coding DNA bearing BG
and bis-biotin labels). Given that tens of thousands of POI
molecules are typically produced from each gene by in vitro
expression (Courtois et al., 2008), the introduction of spiking
anchors after PCR amplification enables capture of additional
protein copies. Thus, the display frequency can be set inde-
pendently of the efficiency of the template amplification. The
efficacy of in vitro expression is dependent on the size of the
protein and also on the volume of the droplet compartment,
but .30 000 copies per droplet from a single DNA template
in solution have been observed (Courtois et al., 2008).
Commercial beads (of 5 mm diameter) carry .3  107 biotin-
binding sites in total, so even relatively inefficient in vitro
expression (i.e. 100 copies per template) should lead to
sufficient amounts of protein molecules to decorate all spiking
anchors, ensuring control over a pre-set, constant display fre-
quency. Given that efficient PCR amplification of larger tem-
plates can be difficult to achieve, the ability to uncouple
display success from efficient PCR safeguards against a bottle-
neck is the first step of this procedure. Longer genes or genes
with high GC content that amplify less efficiently can thus still
be used without compromising protein display frequency.
Similarly, the use of proofreading but less efficient poly-
merases becomes possible. Control over the number of dis-
played POI copies facilitates subsequent screening by
normalizing the number of protein molecules displayed. In
yeast and bacterial display dual color selections are used for
this purpose (Boder and Wittrup, 1997; Löfblom et al., 2005),
while here this level of control is taken care of by addition of a
uniform number of anchor molecules (that is larger than the
number of PCR products). The total number of BG functional-
ities per bead can be measured by RT-PCR (by quantifying
both the ePCR products and the anchors), allowing precise de-
termination of display levels. To probe experimentally how
the number of DNA templates and anchors determined the
display level, the amounts of both species to be immobilized
on the beads were varied. SNAP-GFP was expressed from
these display constructs (with increasing displayed copy
numbers of DNA template and with a near-constant number of
Fig. 4. Amplification of bead-bound DNA is possible for templates above 2.7 kb. Amplification was performed (A) by ePCR on beads and (B) by ordinary
solution PCR (in the absence of beads and emulsion). Using the procedure in the Experimental Section (Steps 1–3) it was possible to amplify amplicons ranging
from 357 to 2752 bp. After ePCR, the amplicons were purified. A second PCR reaction was used to render the products visible on gel (see Supplementary Table SI
for the PCR protocol). Note that this second PCR reaction is not part of the BeSD procedure (shown in Fig. 2 and detailed in the Experimental Section) that only
contains a single PCR step. See Table I for the quantification of ePCR yields as a function of polymerase species and template length. The initial number of DNA
template molecules was 1.7  107. The templates were amplified with primers F-BB and R2 (with the exception of the 2752 bp template, where R3 was used
instead of R2). NTC, no template control.
Table I. Amplification efficiencies of different polymerases in ePCR as a
function of template length
Amplicon
length (bp)









357 1.7  107 0.15c 1.1  105 1.3  106 6300.
537 2100 1.5  104 4e
1120 820 5600 8.8e
1806 240 8200 4.6e
2750 640 1000 n.d.
aFor a standard reaction (18 ml).
bCalculated as the ratio between DNA copies and number of beads (9.0  105)
corrected for the probability of both beads and DNA being in the same droplet
(0.0078, i.e. the sum of ‘desired’ and ‘undesired’ probabilities; see
Supplementary Table SI).
cThis number indicates that, on average, one in every 6.8 beads will bear
DNA.
dCalculated via RT-PCR on 500 beads per sample. Values represent the
average of three measurements and showed standard deviation within 10%,
unless otherwise stated.
eStandard deviation exceeded 10%.
n.d., not detectable.
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anchors of around 105). The fluorescence of the supernatant
(reporting on the excess of GFP that was not captured by the
anchors) and on beads (reporting on the GFP captured by the
anchors) was measured to quantify when saturation occurs
(using a procedure illustrated in Supplementary Fig. S5B).
Figure 5A shows that more protein molecules are expressed
than display functionalities (template DNA and anchors) are
present. This picture is mirrored by the saturation of the GFP
fluorescence levels coupled to the beads (Fig. 5B). This type
of experiment will be useful to test initially unknown in vitro
expression and display efficiencies: as long as an increase in
bead-bound fluorescence is observed with increasing template
or anchor concentrations, the number of display functional-
ities, rather than expression, limits display levels (i.e. the
protein expression is efficient enough to label all displayed
DNA molecules). Under standard experimental conditions all
105 available display functionalities provided by spiking
anchors are successfully decorated with expressed protein. To
exclude the possibility of exchange of DNA molecules
between beads, the stability of the SNAP-HA construct was
tested in isolation or mixed with an equal amount of beads that
did not display the tag. The fluorescence distribution after 1 h
of incubation (i.e. the average time when the beads remain in
solution, without compartment separation, during a standard
cycle of BeSD) still showed two peaks identical with those
of two independent populations, indicating that, at room
temperature, no exchange of the displayed proteins occurs
(Supplementary Fig. S6).
Selection of a binding tag from a random library
To demonstrate the utility of the BeSD method we carried out
a selection for a peptide binder from a randomized sequence.
A construct was built in which the HA-tag (Field et al., 1988)
was fused to the SNAP-tag. The HA-tag sequence
(YPYDVPDYASL) was randomized by introducing a degen-
erate NNS codon in position D7 (library HA-D7). Following
the procedure illustrated in Fig. 2, the displayed HA-D7
library was tested for binding against an Alexa488-labeled
anti-HA antibody. Flow cytometric analysis showed that the
HA-D7 library contained proteins with dramatically different
binding properties: one fraction was indistinguishable from
the negative control, but there were also binders with WT af-
finity (Fig. 6A). The ability to recover binders depends on the
threshold applied as well as the number of events required for
efficient recovery. The top 0.3% of the population were
selected (Supplementary Fig. S7), individual beads collected
in multiwell plates suitable for PCR, amplified directly and
then sequenced. In 86% of the selected population, the amino
acid aspartate (that is present in the original HA-tag sequence)
had been selected, albeit with alternative codon usage. The
remaining clones (14%) contained asparagine. The sequencing
of random clones from the unsorted library showed the occur-
rence of all other amino acids, suggesting that the original
library was indeed unbiased. Sequencing of DNA amplified
from individual beads confirmed that the first emulsification
process (Fig. 2, step 1) leads to monoclonal display constructs
(as predicted by the Poisson distribution, Supplementary
Table S1). The presence of multiple DNA templates in the
same droplet would lead to beads bearing more than one HA
variant and generate multiple reads when the corresponding
DNA is sequenced. Further evidence for bead monoclonality
comes from the observed enrichment values (see below) and
from SNAP-GFP expression tests (Supplementary Table S2
and Fig. S2). Should the statistically unlikely multiclonal
beads (from the tail of the Poisson distribution) lead to false
positives, multiple rounds of sorting can be used to remove
them (Kintses et al., 2012).
Screening of larger libraries and isolation of alternative
HA-tags
Further randomization was undertaken in the HA-tag residues
guided by the only available structure of an HA-antibody
complex (Churchill et al., 1994). Positions in close contact
with the antibody binding site, namely Asp-7, Tyr-8 and Ala-9
of the HA-tag (Supplementary Fig. S8), were randomized.
Two libraries containing 400 or 8000 variants were con-
structed based on full randomization of either the last two
(HA-Y8A9) or all three positions (HA-D7Y8A9),
Fig. 5. Quantification of the role of spiking anchors in increasing the protein
display level. (A) Expression of SNAP-GFP from DNA immobilized on bead
was measured in the supernatant as a function of the number of DNA
templates and anchors displayed on beads (see Supplementary Fig. S5B for a
schematic explanation of this experiment). Increasing the expression level
(more templates) causes the increase of unbound SNAP-GFP, indicating that
all display functionalities on the beads are already saturated under these
conditions. DNA concentrations were measured by RT-PCR and have
standard deviations below 10%. (NTC, no template control). (B) Fluorescence
measured on beads after the procedure indicated in Supplementary Fig. S5B.
The plot indicates that in the absence of spiking anchors (first set), only a
small amount of SNAP-GFP is immobilized on the bead. In the presence of an
excess of spiking anchors, however, fluorescence on the beads reaches
saturation levels, independently of the amount of template DNA. This
suggests that an excess of protein fusion is produced by each template DNA
copy and that the display levels reach saturation at low template concentration.
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respectively. These libraries were sorted by FACS, collecting
the top 1.18 and 0.45% of the bead populations (HA-Y8A9
and HA-D7Y8A9 libraries, respectively), followed by DNA
amplification for direct sequencing. All of the sequences iso-
lated after one round of screening corresponded to the WT se-
quence (albeit with alternative codon usages) or mutants in
which the character of the WT residues was maintained (e.g.
the preference for bulky, hydrophobic residues in position 8 in
HA-Y8A9 and the presence of asparagine in position 7 in the
HA-D7Y8A9 and HA-D7 libraries, see Table II). The variants
selected with higher frequency (D7Y8S9 and N7Y8A9, to-
gether with the rationally designed combination between these
two N7Y8S9), two variants isolated from gates with lower
fluorescence (HA-G7 and HA-L7), and the WT were then
expressed in vitro (without emulsification) and immobilized
on the beads via anchors. FACS measurements of populations
of beads displaying these variants (Fig. 6B) indicate that
D7Y8S9 and N7Y8A9 possess a fluorescence distribution
similar to the WT, as does their combination N7Y8S9. As
expected, unselected controls (mutants HA-G7 and HA-L7)
have lower mean fluorescence values consistent with reduced
affinities for the anti-HA antibody. Thus, fluorescence can be
used as a proxy for binding affinity (see also Fig. 7 below).
The enrichment in these selections was quantified by compar-
ing the theoretical hit rate and actual recovery. This compari-
son gave an ideal recovery for the 1-NNS library and half of
the ideal recovery for the 3-NNS library (2000-fold).
On-bead Kd measurements
Some of the variants in Fig. 6B were BeSD-displayed, incu-
bated with increasing concentrations of Alexa488-labeled
anti-HA antibody and their fluorescence analyzed by flow cyto-
metry. The Kd was determined by fitting the normalized median
fluorescence into a Hill curve (Fig. 7 and supplementary Fig.
S9). The curve fit indicates that four variants (HA-tag WT,
N7Y8A9, N7Y8S9 and D7Y8S9) possess affinities in the low
nanomolar range. The newly isolated HA-tag variants show dis-
sociation constants very similar to that of the WT (the data for
N7Y8S8, the weakest binder, can be fit to a Kd of 20.7+
1.6 nM, compared with 11.7+1.1 nM for the WT). Control
mutants randomly picked from the unsorted library (HA-L7 and
HA-T7K8L9) did not show any saturation even at the highest
antibody concentration (450 nM). The correlation between Kd
(Fig. 7) and fluorescence level under screening conditions
(Fig. 6B) suggests that in BeSD, the binders are quantitatively
ranked and screened on the basis of their affinity for the target.
Variants isolated in the same FACS gate (here representing the
top 1% of the population, Fig. 6A) differ by as little as 2-fold,
suggesting that stringent screening with high resolution is pos-
sible. The use of BeSD as a display system combined with flow
cytometry offers a quick platform to measure the relative dis-
sociation constant of protein variants. By contrast, affinity quan-
tification is not possible in phage display and other in vitro
display methods. When bead display systems were applied to
selections of binders, the hits were either identified by tyramide
Fig. 6. Screening and sorting of the library HA-D7. (A) Fluorescence
distribution of negative control beads (ePCR without template, gray), beads
expressing the SNAP-tag alone (blue), the HA-D7 library (green) or the WT
HA-tag (black). (B) Characterization of the binding properties of selected
mutants by flow cytometry. Genes coding for HA mutants (selected after one
round of BeSD) were attached to the beads and Steps 4–9 of the standard
BeSD procedure (Fig. 2) were performed but without emulsions. The
bead-displayed HA mutants shown are HA-G7 (red), HA-L7 (orange), the
selected D7Y8S9 (dark blue) and N7Y8A9 (green) and the designed N7Y8S9
(cyan). Higher fluorescence values indicate greater binding affinity of the HA
mutants to Alexa Fluorw 488-conjugate anti-HA antibody (Invitrogen).
Controls include beads without template DNA (dark gray), beads displaying
the SNAP-tag only (negative control, light gray), and WT HA (black).
Table II. Sequences of HA variants selected by BeSD
Positions randomized in each library are indicated in bold and underlined. The
cell shading highlights mutants that emerged more than once in selections.
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signal amplification that does not allow selection for affinity
(Sepp et al., 2002) or could not be quantitatively ranked (Gan
et al., 2008, 2010). The BeSD thus emulates the hitherto unique
ability of cell display systems to carry out affinity selections
based on a strict quantitative selection criterion.
Conclusions
The BeSD differs in several important respects from the cur-
rently used display systems. In contrast to bacterial, yeast or
phage display, protein expression occurs in vitro, so that pro-
teins toxic to the host organism can be displayed. Limits of
transformation efficiency (Amstutz et al., 2001) into yeast
(107–108/mg DNA) and bacteria (109–1010/mg DNA)
that lead to loss of library diversity can be overcome.
However, screening remains a bottleneck for the BeSD: the
throughput of flow cytometric sorting (FACS) is limited at
around 108 clones per day, so that the actual library size
probed is more similar to bacteria and yeast display. Similar to
these techniques, selections based on fine quantification of the
saturation level of a binding curve are possible, allowing deep
mining of repertoires of protein binders. The genotype is
encoded as DNA (rather than as RNA, as in ribosome and
mRNA display) and benefits from a step of amplification via
PCR that improves expression and recovery. Other methods
relied on just one copy of the gene of interest (Sepp et al.,
2002; Griffiths and Tawfik, 2003), which imposes limits on
two fronts. On the one hand, recovery of a single gene copy
can be challenging, while the availability of multiple tem-
plates in the BeSD ensures that all of the selected clones are
also identified after PCR and sequencing. On the other hand,
more DNA templates lead to more expressed protein mole-
cules, so that the phenotype can be recognized with better sen-
sitivity. Indeed, only one, already very fast enzyme could be
evolved in a bead display format (Griffiths and Tawfik, 2003),
suggesting that when starting from one gene copy, insufficient
protein is expressed to make slower catalysts amenable to evo-
lution. Control over the number of display functionalities on
beads can be used further to adjust the selection stringency
and normalize display levels, a key feature to avoid bias
during the screening step caused by differing expression. This
level of control contrasts with previous studies in which the
number of displayed proteins was not explicitly quantified or
controlled (Gan et al., 2008, 2010; Stapleton and Swartz,
2010; Paul et al., 2013).
Identification of a hit depends on the functional ranking of
all of the variants in the library. The high genotype copy
number enables DNA recovery from a single bead and pro-
vides the possibility to sequence individual variants, without
the need for repetitive cycles of enrichment and switching
from high- to low- throughput methods. Finally, the display
construct is held together by covalent (thioether) and strong,
non-covalent and reversible (biotin–streptavidin) interactions,
compared with, for example, a potentially unstable adduct in
ribosome display. Previously, linkages of the phenotype to
beads were achieved via much weaker non-covalent bonds
(namely antibodies (Sepp et al., 2002) or the strep-tag (Gan
et al., 2010)) and the same functionality was used to bind both
the DNA and the displayed proteins. The BeSD relies on con-
ventional techniques (PCR, bulk emulsions and FACS) and on
the modular combination of highly controllable steps (decor-
ation of beads, binding stringency and sorting). The potential
of the BeSD for the evolution and isolation of new protein
binders is based on the following properties:
(i) Genotypic redundancy. Until now, inefficient PCR
reactions have prevented decoration of beads with
large numbers of copies of coding DNA. The avail-
ability of up to 106 templates (depending on the type
of polymerase and the length of the gene, Table I)
increases the chances of recovery by PCR, ensuring
that the hits are identified. Here, the increase in amp-
lification efficiency afforded by slow cooling after
the PCR cycles leads to production of more
Fig. 7. Measurement of binding curves of proteins displayed on the beads by
flow cytometry. (A) Comparison of WT HA-tag (open squares) with
non-binding clones (that were randomly picked from the unsorted library;
T7K8L9, red circles and L7Y8A9, blue triangles) and the negative control
(beads without DNA, black squares). Inset: enlargement of the same plot
excluding the WT data. Note that while the negative control shows a flat line,
the two HA-tag variants show an increase in fluorescence that suggests that
binding to the anti-HA antibody is occurring and can be quantified (albeit not
showing full saturation). (B) BeSD display constructs of the WT HA-tag
(black squares) and variants isolated from library HA-D7Y8A9 (N7Y8A9,
green circles), from library HA-Y8A9 (D7Y8S9, dark blue triangles) and the
designed N7Y8S9 (cyan triangles). The beads were incubated with
Alexa488-labeled anti-HA antibody (in the range 0.1–450 nM, corresponding
to a molar excess of 1–350 times the total number of displayed proteins per
sample). A curve fit to the Hill equation gave the following Kd values: HA-tag
WT (11.7+1.1 nM), N7Y8A9 (17.5+1.4 nM), N7Y8S9 (20.7+1.6 nM)
and D7Y8S9 (15.5+1.1 nM). The gray box denotes the anti-HA antibody
concentrations at which selections were carried out.
L.Diamante et al.
722
templates than previously possible. Moreover, an ac-
curate quantification of PCR products attached to
the beads is achieved by RT-PCR. In previous bead
display systems, only one copy was displayed (Sepp
et al., 2002; Griffiths and Tawfik, 2003) or the
number of amplified templates was not quantified
(Gan et al., 2008, 2010; Stapleton and Swartz, 2010;
Paul et al., 2013). The amplification and expression
of SNAP-HA leads to homogeneous fluorescence
signals 20- to 100-fold higher than background
noise. Samples that did not undergo ePCR
(Supplementary Fig. S1) show a fluorescence signal
that is indistinguishable from the background.
Incorporation of an ePCR step was therefore essen-
tial to increase the dynamic range of the method.
(ii) Phenotypic redundancy. Protein expression levels in
IVTT can substantially exceed the number of coding
DNA molecules (by several orders of magnitude).
For example, it has been shown that one copy of
template DNA is sufficient to produce .30 000
copies of GFP (Courtois et al., 2008). This quantifi-
cation suggests that this process can be very efficient
indeed. Starting with multiple template molecules in
the BeSD is likely to produce even more protein
molecule (although it would be optimistic to assume
proportionality). It has been shown that a substantial
number of a given proteome can be functionally
expressed in vitro (Davies et al., 2005; Madono
et al., 2011), although specific candidates can of
course present expression or folding problems, as in
any other system. As a high protein display fre-
quency is necessary to carry out sensitive screening
assays, a boost in the amount of displayed proteins
can be achieved via decoration of the beads with
spiking anchors. In this work, we were able to intro-
duce up to 106 spiking anchors via which proteins
would be displayed. In cases when it is impossible
to generate large numbers of DNA templates by
PCR (for example, when use of a proofreading
enzyme is required or when the efficiency of the
PCR is hampered by difficult templates), this meth-
odology allows the display of a larger number of
proteins. At the same time, the ability to control the
number of spiking anchors normalizes display levels
and neutralizes the effects of stochastic fluctuations
in PCR efficiency. In yeast display, the number of
displayed molecules is similar to the display level
that has been shown to be achieved in vitro from one
template copy in droplets (Courtois et al., 2008), but
is not easily adjustable. In BeSD, the number of dis-
played molecules can be chosen at will and is pre-
determined, so that the quantification of individual
expression levels is not required and laborious pro-
cedures of double staining (Boder and Wittrup,
1997; Löfblom et al., 2005) can be avoided.
(iii) The potential for variable DNA and protein display
frequency. The display frequencies can be easily
controlled: in the case of template DNA by adjust-
ment of the PCR conditions and in the case of
protein display levels by addition of a pre-defined
number of spiking anchors (potentially between 0
and 106).
(iv) Affinity assessment of selected variants on-beads.
While it is not possible to quantify the affinity of
proteins displayed on phages or ribosomes, beads
combined with flow cytometry offer quick access to
relative dissociation constants of the selected var-
iants (reflecting Kd). The same BeSD construct can
be used to measure binding saturation curves and
thus quantify the affinities of selected mutants.
The ability to display proteins and peptides with a robust and
flexible procedure opens up the opportunity to implement direc-
ted evolution strategies in which the variants are structurally
modified by addition of features designed to improve ‘drugg-
ability’ (i.e. protease resistance, serum half-live and pharmaco-
kinetics). The condition for successful chemical modification
of a displayed protein prior to selection (‘stapling’) (Verdine
and Walensky, 2007; Heinis et al., 2009; Kutchukian et al.,
2009) is that the display construct is stable enough and compat-
ible with the chemical reactions performed on it. The stable
biotin–streptavidin interaction and the covalent SNAP-tag
should fulfill this criterion. Alternatively, non-natural amino
acids (N-methylated amino acids or unnatural side chains)
(Josephson et al., 2005; Goto and Suga, 2012; Hipolito and
Suga, 2012), can in principle be incorporated via the BeSD, e.g.
when flexizyme (Morimoto et al., 2011) is added to activate a
range of non-natural amino acids for in vitro incorporation.
Future selection formats based on the BeSD are in principle
not limited to selections for protein binders. Selections involv-
ing covalent capture of transition state analogs or suicide sub-
strates that lead to covalent capture have already been shown
in other display formats. (Amstutz et al., 2002; Cesaro-Tadic
et al., 2003; Seelig and Szostak, 2007; Chen et al., 2011) Here,
a single turnover marks a library member as a successful cata-
lyst. In the BeSD, the availability of up to 106 valencies allows
catalytic efficiency to be measured by a count of the number
of turnovers performed in a unit of time over a wide range. As
a consequence, the dynamic range of the BeSD should be
expanded by orders of magnitude beyond that of monovalent
display methods, but future studies will have to show whether
this can indeed be experimentally realized.
In summary, the BeSD provides a versatile new tool for
directed evolution of functional proteins. Combining robust,
reliable and simple procedures, the BeSD should be readily ac-
cessible to a wide circle of protein engineers, while at the
same time giving access to unprecedented degrees of freedom
by combining features of widely used selection formats that
are currently mutually exclusive.
Supplementary data
Supplementary data are available at PEDS online.
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